Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Samus Therapeutics Launches PU-AD Clinical Program in Alzheimer's Disease

americanpharmaceuticalreviewJuly 24, 2019

Tag: Samus Therapeutics , clinical program , Alzheimer's Disease

PharmaSources Customer Service